Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.0750
-0.0040 (-5.06%)
Oct 30, 2026, 12:28 PM AEDT
Vectus Biosystems Market Cap
Vectus Biosystems has a market cap or net worth of 4.66 million as of October 29, 2026. It is the 46,430th most valuable company in the world and the 1,537th biggest in Australia. Its market cap has decreased by 32.73% in one year.
Market Cap
4.66M
Enterprise Value
1.69M
Revenue
2.77M
Global Rank
Country Rank
#1,537 Australia
PE Ratio
2.67
ChartMarket Cap Chart
Since February 23, 2016, Vectus Biosystems's market cap has decreased from 36.22M to 4.66M, a decrease of -87.12%. That is a compound annual growth rate of -17.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 4.66M | -51.51% |
| Dec 31, 2025 | 9.62M | 134.56% |
| Dec 23, 2024 | 4.10M | -74.31% |
| Dec 29, 2023 | 15.96M | -58.89% |
| Dec 30, 2022 | 38.83M | -15.39% |
| Dec 31, 2021 | 45.89M | 20.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 10.33M |
| AdAlta | 9.64M |
| Invex Therapeutics | 7.52M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Bio-Gene Technology | 5.69M |
| Biotron | 5.57M |
| Tissue Repair | 5.44M |